VOXX International (VOXX) said its board is mulling alternatives, including a potential sale of the company, a sale of segments, operational enhancements, or other strategic transactions.
The stock surged 74% as intraday volume topped 110.4 million shares versus the daily average of about 158,000.
Trinity Biotech (TRIB) said late Monday it received substantial additional orders for TrinScreen HIV, leading to an increase in its 2024 sales revenue outlook for the product to $10 million from $8 million.
Shares jumped 48% as volume topped 63.8 million versus the daily average of about 116,000.
Addex Therapeutics (ADXN) said its collaboration partner Indivior selected a clinical candidate from their research partnership.
Shares advanced 39% as volume topped 15.2 million versus the daily average of about 4,000.
Price: 4.97, Change: +2.12, Percent Change: +74.39
Comments